+323.5%
CORZ vs GSK
+42.7%
+280.9%
-64.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +11.0% | -1.2% | +12.2% | +10.5% |
| 7D | +14.2% | -1.1% | +15.3% | +13.7% |
| 30D | -3.0% | +7.8% | -10.8% | +0.1% |
| 3M | -26.3% | +0.3% | -26.6% | -25.3% |
| 6M | -36.5% | +3.4% | -40.0% | -34.9% |
| YTD | +0.1% | +5.9% | -5.8% | +4.0% |
| 1Y | -15.9% | +8.2% | -24.1% | -12.0% |
| All | +323.5% | +42.7% | +280.9% | +414.1% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling